CBD oil's popularity surges across wellness and pharmaceutical sectors, lauded for potential benefits like pain and anxiety ...

One seller claimed the oil wouldn’t affect a drug test, but that is exactly what happened after a former Charlotte police ...

Two bioactive ingredients in cannabis have been found to have antifungal properties when applied topically, according to a ...

A new study uncovers widespread mislabeling in CBD gummies, raising concerns about product accuracy, consumer trust, and the need for stronger regulations.

As the destigmatization of cannabinoids strengthens, CBD gummies continue to be a leading product standardizing wellness ...

1 The randomized, double-blind trial evaluated a pharmaceutically manufactured, good manufacturing practice (GMP)–grade CBD drug in 89 adults with a history of cardiovascular disease (CVD ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

Pharmaceutically made cannabidiol targeting myocarditis did not increase cardiovascular events in at-risk patients, a ...

Analysis of CBD Patches Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea ROCKVILLE , MD, UNITED STATES, June 19, 2025 ...

A new study found that cannabis-derived compounds, cannabidiol (CBD) and cannabidivarin (CBDV) may effectively treat various ...

CBD, but not THC, may counteract the impact of a dysfunctional endogenous cannabinoid system in schizophrenia.